Affitech A/S - Product Pipeline Review - 2013

Market: Pharmaceuticals and Healthcare

Global, 34 pages report, published by Global Markets Direct

Keywords : Current R&D Portfolio of Affitech A/S; Affitech A/S - Key Therapeutics; Affitech A/S - Pipeline Overview and Promising Molecules; Affitech A/S - News; Affitech A/S - Latest Updates; Affitech A/S - Pipeline; Affitech A/S - Discontinued/Dormant Projects

Report ThumbnailAugust-2013
Affitech A/S - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Affitech A/S - Product Pipeline Review - 2013” provides data on the Affitech A/S’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Affitech A/S’s corporate website, SEC filings, investor presentations and featured press releases, both from Affitech A/S and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Affitech A/S - Brief Affitech A/S overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Affitech A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Affitech A/S with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Affitech A/S’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Affitech A/S’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Affitech A/S in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Affitech A/S’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Affitech A/S.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Affitech A/S and identify potential opportunities in those areas.
  • List of Figures
  • Affitech A/S - Pipeline by Indication, 2013 7
  • Affitech A/S - Pipeline by Stage of Development, 2013 9
  • Affitech A/S - Monotherapy Products in Pipeline, 2013 10
  • Affitech A/S - Pipeline By Therapeutic Class, 2013 24
  • Affitech A/S - Pipeline Products By Mechanism of Action, 2013 28
  • List of Tables
  • Affitech A/S, Key Information 5
  • Affitech A/S, Key Facts 5
  • Affitech A/S - Pipeline by Indication, 2013 8
  • Affitech A/S - Pipeline by Stage of Development, 2013 9
  • Affitech A/S - Monotherapy Products in Pipeline, 2013 10
  • Affitech A/S - Phase I, 2013 11
  • Affitech A/S - Preclinical, 2013 12
  • Affitech A/S - Discovery, 2013 13
  • Affitech A/S - Pipeline By Therapeutic Class, 2013 25
  • Affitech A/S - Pipeline By Target, 2013 26
  • Affitech A/S - Pipeline By Route of Administration, 2013 27
  • Affitech A/S - Pipeline Products By Mechanism of Action, 2013 28
  • Affitech A/S - Recent Pipeline Updates, 2013 29
  • Affitech A/S - Dormant Developmental Projects,2013 31
  • Affitech A/S, Other Locations 32
  • Table of Contents
  • Table of Contents 2
  • List of Tables 4
  • List of Figures 4
  • Affitech A/S Snapshot 5
  • Affitech A/S Overview 5
  • Key Information 5
  • Key Facts 5
  • Affitech A/S - Research and Development Overview 6
  • Key Therapeutic Areas 6
  • Affitech A/S - Pipeline Review 9
  • Pipeline Products by Stage of Development 9
  • Pipeline Products - Monotherapy 10
  • Affitech A/S - Pipeline Products Glance 11
  • Affitech A/S Clinical Stage Pipeline Products 11
  • Phase I Products/Combination Treatment Modalities 11
  • Affitech A/S - Early Stage Pipeline Products 12
  • Preclinical Products/Combination Treatment Modalities 12
  • Discovery Products/Combination Treatment Modalities 13
  • Affitech A/S - Drug Profiles 14
  • AT-001 14
  • Product Description 14
  • Mechanism of Action 14
  • R&D Progress 14
  • AT-002 15
  • Product Description 15
  • Mechanism of Action 15
  • R&D Progress 15
  • AT-004 16
  • Product Description 16
  • Mechanism of Action 16
  • R&D Progress 16
  • AT-005 17
  • Product Description 17
  • Mechanism of Action 17
  • R&D Progress 17
  • AT-006 18
  • Product Description 18
  • Mechanism of Action 18
  • R&D Progress 18
  • AT-008 19
  • Product Description 19
  • Mechanism of Action 19
  • R&D Progress 19
  • AT-009 20
  • Product Description 20
  • Mechanism of Action 20
  • R&D Progress 20
  • EP-1300 21
  • Product Description 21
  • Mechanism of Action 21
  • R&D Progress 21
  • GPCR Program 22
  • Product Description 22
  • Mechanism of Action 22
  • R&D Progress 22
  • PGN-635 23
  • Product Description 23
  • Mechanism of Action 23
  • R&D Progress 23
  • Affitech A/S - Pipeline Analysis 24
  • Affitech A/S - Pipeline Products by Therapeutic Class 24
  • Affitech A/S - Pipeline Products By Target 26
  • Affitech A/S - Pipeline Products by Route of Administration 27
  • Affitech A/S - Pipeline Products By Mechanism of Action 28
  • Affitech A/S - Recent Pipeline Updates 29
  • Affitech A/S - Dormant Projects 31
  • Affitech A/S - Locations And Subsidiaries 32
  • Head Office 32
  • Other Locations & Subsidiaries 32
  • Appendix 33
  • Methodology 33
  • Coverage 33
  • Secondary Research 33
  • Primary Research 33
  • Expert Panel Validation 33
  • Contact Us 34
  • Disclaimer 34

Please select a license type

Share

Related Products

Global Markets DirectAffitech A/S - Product Pipeline Review - 2013Product ThumbnailAffitech A/S - Product Pipeline Review - 2013, Industry ReportProduct #: 113363
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved